According to Aerie Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is C$0.30 Billion. In 2021 the company made a revenue of C$0.24 Billion an increase over the revenue in the year 2020 that were of C$0.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | C$0.27 B | 11.43% |
2021 | C$0.24 B | 133.39% |
2020 | C$0.10 B | 16.14% |
2019 | C$91.27 M | 177.11% |
2018 | C$32.93 M | |
2017 | N/A | |
2016 | N/A | |
2015 | N/A | |
2014 | N/A | |
2013 | N/A |